THC
17.3–19.6%
CBD
0.2%
Kamamist is an unclaimed hybrid testing 17 to 20 percent THC, with no documented flavor, effect, or medical profile.
No effect, terpene, flavor or medical-use data specific to Kamamist has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
19.6% THC
About Kamamist
No breeder claims Kamamist, leaving the strain to stand on its lab numbers alone: THC testing between about 17 and 20 percent, a comfortably moderate range. The name doesn't map to any obvious flavor or lineage reference, and nothing about terpenes, flavor, effects, or medical use has been documented to fill that gap in. Unattributed hybrids like this often move between smaller markets under slightly different spellings before a clear origin gets established, and Kamamist looks to be in an early, undocumented stage of that process. What can be said with confidence is limited: a moderate-strength hybrid, tested but otherwise unclaimed and undescribed. For buyers who care more about the number on the label than the story behind it, that's enough information to make a decision; for anyone wanting more, this one currently offers little else.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Kamamist
Is Kamamist an Indica, Sativa, or Hybrid?
Kamamist is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Kamamist?
Kamamist: 19.6% THC and 0.2% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.